Ann: Recording - Special briefing with Prof. Toby Coates, page-5

First 5 Last

Share
Profile

Follow
MattKeaton

212 Posts.

10

16/07/25

14:12

Post #: 79818491
Share

Originally posted by CharliePrince1: ↑

Plenty of benefits even if insulin still needs to be administered.

Less insulin may be required over time - which is already a bonus.
It can reduce the need for continuous glucose monitoring.
It would also reduce the risk of severe hypoglycemia (something that diabetics can be very fearful of as it causes dizziness, seizures, coma or even death).
The real benefit is that you get improved blood glucose control over long periods of time with a better HbA1c reading (this test reflects the average blood glucose in the last few months) and this would help to slow the progression of long term diabetes complications of which there are numerous (renal disease, heart disease, neuropathy, peripheral arterial disease, vision loss, infection risk etc.).

I think it was pretty telling that people who were in this trial said they would be keen to be part of any future trials. That goes to show that the procedure couldn't have been too invasive, that they didn't have a problem living with a small patch of BTM, and that they see a benefit or potential benefit.

Expand

Thanks for this input. Benefits seem to be well understood in the medical community and (as you say) by patients. Is there any insight into the appetite of a public health system to subsidise the product for this application?

Last edited by MattKeaton: 16/07/25

PNV Price at posting: $1.18 Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BEO

One of the biggest jumps today is the most obscure: Beonic Ltd up +65%

ASX Market Close: Index treads water as Energy stocks lead

HotCopper Trends: Vection's $7M, Liontown dips & Wildcat PFS

EMD

Emyria Advances kicks off National Rollout with Avive Health Agreement

WC8

Wildcat’s PFS elicits lacklustre response

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.23		Change -0.015(1.21%)		Mkt cap ! $846.2M

Open	High	Low	Value	Volume
$1.22	$1.25	$1.21	$2.147M	1.755M

Buyers (Bids)

No.	Vol.	Price($)
2	3750	$1.22

Sellers (Offers)

Price($)	Vol.	No.
$1.23	3890	2

View Market Depth

No.	Vol.	Price($)
2	3750	1.220
6	73300	1.210
1	2000	1.205
21	96564	1.200
1	1200	1.195

Price($)	Vol.	No.
1.230	3890	2
1.240	50000	1
1.250	10000	1
1.260	595	1
1.270	10500	2

Last trade - 16.10pm 29/07/2025 (20 minute delay)

PNV (ASX) Chart

Ann: Recording - Special briefing with Prof. Toby Coates, page-5

One of the biggest jumps today is the most obscure: Beonic Ltd up +65%

ASX Market Close: Index treads water as Energy stocks lead

HotCopper Trends: Vection's $7M, Liontown dips & Wildcat PFS

Emyria Advances kicks off National Rollout with Avive Health Agreement

Wildcat’s PFS elicits lacklustre response

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Recording - Special briefing with Prof. Toby Coates, page-5

Top Stories

One of the biggest jumps today is the most obscure: Beonic Ltd up +65%

ASX Market Close: Index treads water as Energy stocks lead

HotCopper Trends: Vection's $7M, Liontown dips & Wildcat PFS

Emyria Advances kicks off National Rollout with Avive Health Agreement

Wildcat’s PFS elicits lacklustre response

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News